Catalyst Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Catalyst Capital Advisors LLC
- $4.66 Billion
- Q4 2024
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$322 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$313 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$311 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$265 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$253 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.89B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...